Charles Fisher

Charles Fisher, CEO of Unlearn.AI, dives into how his company is harnessing machine learning to overhaul clinical trials and accelerate drug development. He discusses the innovative use of AI to create digital twins for simulating patient outcomes, potentially transforming the traditional trial model. Fisher also shares insights on how improved data accuracy through wearable tech can enhance patient experiences. Plus, he explains Unlearn.AI’s unique business model and the future of AI's role in medical research.